Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics

Behavioural Brain Research

Volumn 219, Issue 1, 2011, Pages 98-107

  Wooters, Thomas E ^a   Bardo, Michael T ^a   Dwoskin, Linda P ^b   Midde, Narasimha M ^c   Gomez, Adrian M ^c   Mactutus, Charles F ^c   Booze, Rosemarie M ^c   Zhu, Jun ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Behavioral sensitization; Dopamine transporter; Environmental enrichment; Methylphenidate; Prefrontal cortex; Protein kinase C

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; METHYLPHENIDATE; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOWN REGULATION; ENVIRONMENTAL ENRICHMENT; LOCOMOTION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REARING; SOCIAL STATUS; VELOCITY;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENT; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78751647418     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.001     Document Type: Article

References (79)

1. Bowling S.L., Rowlett J.K., Bardo M.T. The effect of environmental enrichment on amphetamine-stimulated locomotor activity, dopamine synthesis and dopamine release. Neuropharmacology 1993, 32:885-893.
2. Zhu J., Green T., Bardo M.T., Dwoskin L.P. Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex. Behav Brain Res 2004, 148:107-117.
3. Green T.A., Cain M.E., Thompson M., Bardo M.T. Environmental enrichment decreases nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) 2003, 170:235-241.
4. Bowling S.L., Bardo M.T. Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared rats. Pharmacol Biochem Behav 1994, 48:459-464.
5. Bardo M.T., Valone J.M., Bevins R.A. Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration. Psychopharmacology (Berl) 1999, 143:39-46.
6. Bardo M.T., Klebaur J.E., Valone J.M., Deaton C. Environmental enrichment decreases intravenous self-administration of amphetamine in female and male rats. Psychopharmacology (Berl) 2001, 155:278-284.
7. Zhu J., Bardo M.T., Green T.A., Wedlund P.J., Dwoskin L.P. Nicotine increases dopamine clearance in medial prefrontal cortex in rats raised in an enriched environment. J Neurochem 2007.
8. Bardo M.T., Bowling S.L., Rowlett J.K., Manderscheid P., Buxton S.T., Dwoskin L.P. Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacol Biochem Behav 1995, 51:397-405.
9. Baler R.D., Volkow N.D. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 2006, 12:559-566.
10. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 2005, 8:1458-1463.
11. Perry J.L., Stairs D.J., Bardo M.T. Impulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidate. Behav Brain Res 2008, 193:48-54.
12. Perry J.L., Larson E.B., German J.P., Madden G.J., Carroll M.E. Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 2005, 178:193-201.
13. Diergaarde L., Pattij T., Poortvliet I., Hogenboom F., de Vries W., Schoffelmeer A.N., et al. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 2008, 63:301-308.
14. Wood D.A., Siegel A.K., Rebec G.V. Environmental enrichment reduces impulsivity during appetitive conditioning. Physiol Behav 2006, 88:132-137.
15. Hellemans K.G., Nobrega J.N., Olmstead M.C. Early environmental experience alters baseline and ethanol-induced cognitive impulsivity: relationship to forebrain 5-HT1A receptor binding. Behav Brain Res 2005, 159:207-220.
16. Perry J.L., Joseph J.E., Jiang Y., Zimmerman R.S., Kelly T.H., Darna M., et al. Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res Rev 2010.
17. Tannock R., Schachar R.J., Carr R.P., Chajczyk D., Logan G.D. Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 1989, 17:473-491.
18. Tannock R., Schachar R., Logan G. Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abnorm Child Psychol 1995, 23:235-266.
19. Potter A.S., Newhouse P.A. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 2004, 176:182-194.
20. Groman S.M., James A.S., Jentsch J.D. Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. Neurosci Biobehav Rev 2009, 33:690-698.
21. Marsden C.A. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment. Neuropharmacology 2009, 57:577-578.
22. Swanson J.M., Volkow N.D. Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry 2009, 50:180-193.
23. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003, 160:1909-1918.
24. Swanson J.M., Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 2003, 27:615-621.
25. Heron C., Costentin J., Bonnet J.J. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier. Eur J Pharmacol 1994, 264:391-398.
26. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., et al. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 1999, 65:PL7-12.
27. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998, 94:127-152.
28. John C.E., Jones S.R. Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 2007, 52:1596-1605.
29. O'Shaughnessy C.T., Lythgoe D.J., Butcher S.P., Kendall L., Wood B., Steward M.C. Effects of hypoxia on fetal rat brain metabolism studied in utero by 31P-NMR spectroscopy. Brain Res 1991, 551:334-337.
30. Heal D.J., Cheetham S.C., Smith S.L. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 2009, 57:608-618.
31. Wayment H.K., Deutsch H., Schweri M.M., Schenk J.O. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?. J Neurochem 1999, 72:1266-1274.
32. Sandoval V., Riddle E.L., Hanson G.R., Fleckenstein A.E. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J Neurosci 2002, 22:8705-8710.
33. Volz T.J., Farnsworth S.J., King J.L., Riddle E.L., Hanson G.R., Fleckenstein A.E. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J Pharmacol Exp Ther 2007, 323:738-745.
34. Castellanos F.X., Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002, 3:617-628.
35. Rubia K., Halari R., Cubillo A., Mohammad A.M., Scott S., Brammer M. Disorder-specific inferior prefrontal hypofunction in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure conduct disorder during cognitive flexibility. Hum Brain Mapp 2010.
36. Schecklmann M., Romanos M., Bretscher F., Plichta M.M., Warnke A., Fallgatter A.J. Prefrontal oxygenation during working memory in ADHD. J Psychiatry Res 2010, 44:621-628.
37. Stahl S.M. The prefrontal cortex is out of tune in attention-deficit/hyperactivity disorder. J Clin Psychiatry 2009, 70:950-951.
38. Yang P.B., Swann A.C., Dafny N. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res 2006, 1073-1074:164-174.
39. Amini B., Yang P.B., Swann A.C., Dafny N. Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci 2004, 114:1063-1084.
40. Yang P.B., Swann A.C., Dafny N. Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci 2003, 73:2899-2911.
41. Lee M.J., Swann A.C., Dafny N. Methylphenidate sensitization is prevented by prefrontal cortex lesion. Brain Res Bull 2008, 76:131-140.
42. Wooters T.E., Dwoskin L.P., Bardo M.T. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) 2006, 188:18-27.
43. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60:1111-1120.
44. Sesack S.R., Hawrylak V.A., Melchitzky D.S., Lewis D.A. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cereb Cortex 1998, 8:614-622.
45. Yamamoto B.K., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 1998, 71:274-280.
46. Zhu J., Apparsundaram S., Bardo M.T., Dwoskin L.P. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. J Neurochem 2005, 93:1434-1443.
47. Zhu J., Reith M.E. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets 2008, 7:393-409.
48. Daniels G.M., Amara S.G. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 1999, 274:35794-35801.
49. Melikian H.E. Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol Ther 2004, 104:17-27.
50. Zahniser N.R., Sorkin A. Rapid regulation of the dopamine transporter: role in stimulant addiction?. Neuropharmacology 2004, 47:80-91.
51. Foster J.D., Adkins S.D., Lever J.R., Vaughan R.A. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem 2008, 105:1683-1699.
52. Boudanova E., Navaroli D.M., Stevens Z., Melikian H.E. Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol Cell Neurosci 2008, 39:211-217.
53. Zhu J., Apparsundaram S., Dwoskin L.P. Nicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex. J Pharmacol Exp Ther 2009, 328:931-939.
54. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem 1997, 272:15541-15546.
55. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
56. Zhu J., Bardo M.T., Bruntz R.C., Stairs D.J., Dwoskin L.P. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression. Eur J Neurosci 2007, 26:717-728.
57. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 1998, 18:1979-1986.
58. Smith J.K., Neill J.C., Costall B. Post-weaning housing conditions influence the behavioural effects of cocaine and d-amphetamine. Psychopharmacology (Berl) 1997, 131:23-33.
59. Coolon R.A., Cain M.E. Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats. Pharmacol Biochem Behav 2009, 93:59-66.
60. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science 1999, 284:1670-1672.
61. McDougall S.A., Collins R.L., Karper P.E., Watson J.B., Crawford C.A. Effects of repeated methylphenidate treatment in the young rat: sensitization of both locomotor activity and stereotyped sniffing. Exp Clin Psychopharmacol 1999, 7:208-218.
62. Andersen P.H., Jansen J.A., Nielsen E.B. [3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site. Eur J Pharmacol 1987, 144:1-6.
63. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res 2000, 864:24-39.
64. Easton N., Steward C., Marshall F., Fone K., Marsden C. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology 2007, 52:405-414.
65. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258.
66. Volkow N.D., Wang G.J., Fowler J.S., Ding Y.S. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1410-1415.
67. Huff R.A., Vaughan R.A., Kuhar M.J., Uhl G.R. Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax. J Neurochem 1997, 68:225-232.
68. Zhu S.J., Kavanaugh M.P., Sonders M.S., Amara S.G., Zahniser N.R. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther 1997, 282:1358-1365.
69. Melikian H.E., Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 1999, 19:7699-7710.
70. Granas C., Ferrer J., Loland C.J., Javitch J.A., Gether U. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J Biol Chem 2003, 278:4990-5000.
71. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M.E., et al. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2004, 2:E78.
72. Holton K.L., Loder M.K., Melikian H.E. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat Neurosci 2005, 8:881-888.
73. Del Arco A., Segovia G., Canales J.J., Garrido P., de Blas M., Garcia-Verdugo J.M., et al. Environmental enrichment reduces the function of D1 dopamine receptors in the prefrontal cortex of the rat. J Neural Transm 2007, 114:43-48.
74. Green T.A., Gehrke B.J., Bardo M.T. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules. Psychopharmacology (Berl) 2002, 162:373-378.
75. Swanson C.J., Kalivas P.W. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J Pharmacol Exp Ther 2000, 292:406-414.
76. Sesack S.R., Bunney B.S. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. J Pharmacol Exp Ther 1989, 248:1323-1333.
77. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 1989, 290:213-242.
78. Rahman S., Bardo M.T. Environmental enrichment increases amphetamine-induced glutamate neurotransmission in the nucleus accumbens: a neurochemical study. Brain Res 2008, 1197:40-46.
79. Pamplona F.A., Pandolfo P., Savoldi R., Prediger R.D., Takahashi R.N. Environmental enrichment improves cognitive deficits in spontaneously hypertensive rats (SHR): relevance for attention deficit/hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1153-1160.